Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors

F Linkov, R Edwards, J Balk, Z Yurkovetsky… - European Journal of …, 2008 - Elsevier
PURPOSE: Endometrial carcinoma is the most common cancer of the lower female genital
tract in Europe and the United States. Faced with the growing incidence of endometrial …

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

RG Moore, AK Brown, MC Miller, D Badgwell, Z Lu… - Gynecologic …, 2008 - Elsevier
OBJECTIVE: Tumor markers with increased sensitivity and specificity for endometrial cancer
are needed to help monitor response to therapy and to detect recurrent disease. Currently …

[HTML][HTML] Serum biomarkers for early detection of gynecologic cancers

Y Ueda, T Enomoto, T Kimura, T Miyatake, K Yoshino… - Cancers, 2010 - mdpi.com
Ovarian, endometrial, and cervical cancers are three of the most common malignancies of
the female reproductive organs. CA 125, historically the most reliable serum marker for …

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study

R Angioli, F Plotti, S Capriglione, R Montera, P Damiani… - Tumor Biology, 2013 - Springer
The aim of the study was to explore the clinical value of serum human epididymis secretory
protein E4 (HE4) and CA125 in endometrial carcinoma. From January 2010 to April 2012 …

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer

E Kalogera, N Scholler, C Powless, A Weaver… - Gynecologic …, 2012 - Elsevier
OBJECTIVE: To evaluate the utility of serum (HE4) as a marker for high risk disease in
patients with endometrial cancer (EC). METHODS: Preoperative serum HE4 levels were …

Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer

H Hoon Chung, J Weon Kim, NH Park… - Acta obstetricia et …, 2006 - Taylor & Francis
Background. The purpose of this study was to evaluate the predictive value of preoperative
serum CA-125 levels in the assessment of disease extent and clinical outcome of …

Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial …

Y Todo, N Sakuragi, R Nishida, T Yamada… - American journal of …, 2003 - Elsevier
Objective: The aim of this study was to predict retroperitoneal lymph node metastasis during
the preoperative examination of patients with endometrial carcinoma and to determine …

A novel sandwich electrochemiluminescence immunosensor for ultrasensitive detection of carbohydrate antigen 19-9 based on immobilizing luminol on Ag@ BSA …

A Zhang, H Xiang, X Zhang, W Guo, E Yuan… - Biosensors and …, 2016 - Elsevier
A novel sandwich-type electrochemiluminescence immunosensor based on immobilizing
luminol on Ag@ BSA core/shell microspheres (Ag@ BSA-luminol) for ultrasensitive …

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with …

K Nakamura, N Imafuku, T Nishida, I Niwa, I Joja… - Gynecologic …, 2012 - Elsevier
OBJECTIVE: The purpose of this study was to evaluate whether preoperative measurements
of the minimum apparent diffusion coefficient (ADCmin) on magnetic resonance imaging …

Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma

B Nakata, KHYS Chung, Y Kato… - … Journal of the …, 1998 - Wiley Online Library
BACKGROUND Prediction of peritoneal dissemination is very difficult using current
diagnostic tools such as computed tomography, ultrasonography, or various tumor markers …